Acetabular Bone Vascularity in Metal-on-Metal Revisions
NCT ID: NCT02239406
Last Updated: 2016-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
7 participants
OBSERVATIONAL
2014-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A convenient sample of a consecutive series of 15 patients treated for metal on metal acetabular revision surgery will be included.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty
NCT02208271
Survivorship, Radiographic, and Functional Outcomes of the Multihole Revision Acetabular Cup
NCT03031964
Metal Ions in Ceramic on Metal Total Hip Arthroplasty
NCT01437124
Bone Mineral Density Changes of the Acetabulum After Revision Hip Arthroplasty Using Bone Impaction Grafting
NCT02061904
Metal-on-metal Hip Replacement MRI Study
NCT03409640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who meet all eligibility criteria will have three biopsies performed at the time of their revision surgery. A pathologist will note the presence or absence of bone necrosis and will measure the length (mm) of necrosis, acute inflammation, chronic inflammation, normal bone, and entire bone specimen in order to obtain a ratio.
Biopsy Protocol:
A bone biopsy is a procedure in which bone samples are removed (with a special instrument during surgery) and looked at under a microscope for necrosis (tissue death), infection, or other bone disorders. Once the acetabular hip replacement implants have been removed the following steps will occur:
* The biopsy needle will be inserted into the bone (3 locations; 2 from ilium, 1 from pubis or ischium = 3 total).
* The biopsy needle will be withdrawn and firm pressure will be applied to the biopsy site for a few minutes, until the bleeding has stopped.
* Each bone biopsy sample will be labeled sequentially and by anatomic location (i.e., ilium #1, ilium #2)
* The normal bone will be marked on the bone sample.
* The bone biopsy sample will be sent to the lab for examination.
* The acetabulum bone will be reamed so the new implant can be seated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metal-on-Metal Revision
Patients who have a failed metal on metal total hip implant and are presenting for revision surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is greater than one year postoperative.
* Patient has had cobalt and chromium metal ion levels tested within 6 months of the planned revision surgery.
* Understands the local language and is willing and able to follow the requirements of the protocol.
* Understands the informed consent and signs the institutional review board or independent ethics committee (IRB/IEC) approved informed consent form.
Exclusion Criteria
* Evidence of current substance or alcohol abuse
* Being treated with radiation, chemotherapy, immunosupression, or chronic steroid therapy (prednisone use up to 5 mg/qd or its equivalent is allowed)
* Is a prisoner
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Presbyterian Pathology Group
UNKNOWN
OrthoCarolina Research Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Fehring, MD
Role: PRINCIPAL_INVESTIGATOR
OrthoCarolina Research Institute, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OrthoCarolina
Charlotte, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HK025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.